Growth Metrics

Medicale (MCLE) Equity Ratio (2020 - 2024)

Medicale (MCLE) has disclosed Equity Ratio for 5 consecutive years, with 727.13 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Equity Ratio fell 92.6% year-over-year to 727.13, compared with a TTM value of 727.13 through Dec 2024, down 92.6%, and an annual FY2024 reading of 622.22, down 142.96% over the prior year.
  • Equity Ratio was 727.13 for Q4 2024 at Medicale, down from 622.22 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.15 in Q1 2021 and bottomed at 727.13 in Q4 2024.
  • Average Equity Ratio over 5 years is 221.04, with a median of 112.93 recorded in 2023.
  • The sharpest move saw Equity Ratio plummeted 3363.01% in 2022, then crashed 92.6% in 2024.
  • Year by year, Equity Ratio stood at 1.11 in 2020, then tumbled by 93.12% to 2.15 in 2021, then tumbled by 3363.01% to 74.47 in 2022, then crashed by 406.94% to 377.53 in 2023, then plummeted by 92.6% to 727.13 in 2024.
  • Business Quant data shows Equity Ratio for MCLE at 727.13 in Q4 2024, 622.22 in Q3 2024, and 516.05 in Q2 2024.